Calder Biosciences
Creating Next-Generation Vaccines to Protect Against Infection
* Data source: Crunchbase
- Founded
- 2018
- Employees*
- 2-10
- Funding to Date*
- $15,363,745
- Website
- www.calderbiosciences.com
“Developing increasingly challenging vaccine targets requires increasingly sophisticated technologies.”
Over the last century, vaccines have made essential contributions to the doubling of human life expectancy. Calder engineers next-generation vaccines that will further protect against the most intractable and life-threatening viruses.
Calder is a nano-scale, molecular engineering company that is applying its platform technology to engineer and develop novel vaccines that allow billions of people to stay healthy.
We’re developing safe, effective, durable, and tolerable vaccines that protect against RSV, all strains of seasonal and pandemic influenza, and other harmful, viral infections.
More Companies
